You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新世紀醫療(01518.HK)附屬擬斥1870萬元攬入青島新世紀12.47%權益
格隆匯 01-30 19:48

格隆匯1月30日丨新世紀醫療(01518.HK)宣佈,於2022年1月29日,公司全資附屬嘉華怡和與關連人士嘉華麗康訂立購銷協議,據此,嘉華怡和已有條件同意購買,而嘉華麗康已有條件同意出售相當目標公司嘉華永盛12.47%股權的銷售股份,現金代價為人民幣1870萬元。完成後,公司將間接持有目標公司12.47%股權。

目標公司為一間中國註冊成立的有限公司。其主要從事投資控股。該公吿日期,(i)目標公司由嘉華麗康及獨立第三方北京喬耐森星分別持有80%及20%權益;及(ii)目標公司持有青島新世紀100%權益。北京喬耐森星由獨立第三方李維最終全資擁有。

青島新世紀是一間位中國山東省青島市的二級婦兒專科醫院,提供全面綜合的兒科及婦產科服務,主要科室包括兒童保健、兒童體檢、兒童心理諮詢、兒內全科、新生兒科、小兒神經內科、小兒呼吸科、小兒內分泌科、小兒心血管內科、兒外全科、小兒泌尿外科、小兒骨科、耳鼻喉科、口腔科、眼科、皮膚科、口腔頜面外科、婦科以及產科。青島新世紀的建築面積為2.3萬平方米,擁有註冊牀位102張,包括LDR(待產、生產及休養)牀位七張。

公吿稱,收購事項具戰略重要性,有助進一步增強集團兒科內多個科室的合作競爭優勢、加強兒科子專科建設、提升集團在提供產科及兒科綜合醫療服務方面實力優勢、提升集團醫療服務系統及拓展于山東省的醫療服務覆蓋範圍。

集團一直就青島新世紀的經營及管理為嘉華麗康提供諮詢服務。青島新世紀已形成市場影響力,培訓一支優秀的專業醫療及管理團隊,並打造良好的品牌聲譽。通過收購事項,集團將進一步助力青島新世紀品牌建設、滿足其持續增加的本地市場需求及挖掘進一步業務擴展潛力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account